Vaccine development through terminal deletions of an infectious bursal disease virus protein 2 precursor variant

Process Biochemistry

Volumn 45, Issue 5, 2010, Pages 786-793

  Ho, Jin Yi ^a   Lee, Long Huw ^a   Lin, Yu Chiang ^a   Tai, Yu Jui ^a   Chang, Cheng Kai ^a   Chou, Yu mei ^a   Lai, Su Yuan ^b   Wang, Min Ying ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Baculovirus expression system; Immobilized metal ion affinity chromatography; Infectious bursal disease virus; Subviral particle; Vaccine

Indexed keywords

AMINO ACID RESIDUES; BACULOVIRUS EXPRESSION SYSTEMS; EXPRESSION LEVELS; IMMOBILIZED METALS; INFECTIOUS BURSAL DISEASE VIRUS; INSECT CELLS; LOW DOSAGE; N-TERMINALS; SELF-ASSEMBLE; SINGLE-STEP; ULTRACENTRIFUGATION; VACCINE DEVELOPMENT;

AFFINITY CHROMATOGRAPHY; AMINO ACIDS; CENTRIFUGATION; IONS; METAL REFINING; ORGANIC ACIDS; SCANNING ELECTRON MICROSCOPY; VACCINES; VIRUSES;

ION CHROMATOGRAPHY;

HEXAPODA; INFECTIOUS BURSAL DISEASE VIRUS;

EID: 77950297877     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2010.01.021     Document Type: Article

References (43)

1. Müller H., Islam M.R., and Raue R. Research on infectious bursal disease-the past, the present and the future. Vet Microbiol 97 1-2 (2003) 153-165
2. Cullen G.A., and Wyeth P.J. Response of growing chickens to an inactivated IBD antigen in oil emulsion. Vet Rec 99 21 (1976) 418
3. Berg V.D. Acute infectious bursal disease in poultry: a review. Avian Pathol 29 (2000) 175-194
4. Mundt E., and Müller H. Complete nucleotide sequences of 5′- and 3′-noncoding regions of both genome segments of different strains of infectious bursal disease virus. Virology 209 1 (1995) 10-18
5. Chevalier C., Lepault J., Erk I., Da Costa B., and Delmas B. The maturation process of pVP2 requires assembly of infectious bursal disease virus capsids. J Virol 76 5 (2002) 2384-2392
6. Coulibaly F., Chevalier C., Gutsche I., Pous J., Navaza J., Bressanelli S., et al. The birnavirus crystal structure reveals structural relationships among icosahedral viruses. Cell 120 6 (2005) 761-772
7. Fahey K.J., Erny K., and Crooks J. A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens. J Gen Virol 70 (1989) 1473-1481
8. Becht H., Muller H., and Muller H.K. Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus. J Gen Virol 69 (1988) 631-640
9. Heine H.G., Haritou M., Failla P., Fahey K., and Azad A. Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type I strains. J Gen Virol 72 (1991) 1835-1843
10. Chen C.S., Suen S.Y., Lai S.Y., Chang G.R., Lu T.C., Lee M.S., et al. Purification of capsid-like particles of infectious bursal disease virus (IBDV) VP2 expressed in E. coli with a metal-ion affinity membrane system. J Virol Methods 130 1-2 (2005) 51-58
11. Pitcovski J., Gutter B., Gallili G., Goldway M., Perelman B., Gross G., et al. Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens. Vaccine 21 32 (2003) 4736-4743
12. Bayliss C.D., Spies U., Shaw K., Peters R.W., Papageorgiou A., Muller H., et al. A comparison of the sequences of segment A of four infectious bursal disease virus strains and identification of a variable region in VP2. J Gen Virol 71 (1990) 1303-1312
13. Fernandez-Arias A., Martinez S., and Rodriguez J.F. The major antigenic protein of infectious bursal disease virus, VP2, is an apoptotic inducer. J Virol 71 10 (1997) 8014-8018
14. Martinez-Torrecuadrada J.L., Saubi N., Pages-Mante A., Caston J.R., Espuna E., and Casal J.I. Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines. Vaccine 21 17-18 (2003) 1952-1960
15. Wang M.Y., Kuo Y.Y., Lee M.S., Doong S.R., Ho J.Y., and Lee L.H. Self-assembly of the infectious bursal disease virus capsid protein, rVP2, expressed in insect cells and purification of immunogenic chimeric rVP2H particles by immobilized metal-ion affinity chromatography. Biotechnol Bioeng 67 1 (2000) 104-111
16. Jennings G.T., and Bachmann M.F. The coming of age of virus-like particle vaccines. Biol Chem (2008)
17. Lee C.C., Ko T.P., Chou C.C., Yoshimura M., Doong S.R., Wang M.Y., et al. Crystal structure of infectious bursal disease virus VP2 subviral particle at 2.6 Å resolution: implications in virion assembly and immunogenicity. J Struct Biol 155 1 (2006) 74-86
18. van Loon A.A., de Haas N., Zeyda I., and Mundt E. Alteration of amino acids in VP2 of very virulent infectious bursal disease virus results in tissue culture adaptation and attenuation in chickens. J Gen Virol 83 Pt 1 (2002) 121-129
19. Doong S.R., Chen Y.H., Lai S.Y., Lee C.C., Lin Y.C., and Wang M.Y. Strong and heterogeneous adsorption of infectious bursal disease VP2 subviral particle with immobilized metal ions dependent on two surface histidine residues. Anal Chem 79 20 (2007) 7654-7661
20. Branden C., and Tooze J. The structure of spherical viruses (1999), Garland, New York
21. Bertolotti-Ciarlet A., White L.J., Chen R., Prasad B.V., and Estes M.K. Structural requirements for the assembly of Norwalk virus-like particles. J Virol 76 8 (2002) 4044-4055
22. Chen Y., Ghim S.J., Jenson A.B., and Schlegel R. Mutant canine oral papillomavirus L1 capsid proteins which form virus-like particles but lack native conformational epitopes. J Gen Virol 79 Pt 9 (1998) 2137-2146
23. Choi J., and Loesch-Fries L.S. Effect of C-terminal mutations of alfalfa mosaic virus coat protein on dimer formation and assembly in vitro. Virology 260 1 (1999) 182-189
24. Hurtado A., Rueda P., Nowicky J., Sarraseca J., and Casal J.I. Identification of domains in canine parvovirus VP2 essential for the assembly of virus-like particles. J Virol 70 8 (1996) 5422-5429
25. Kawase M., Momoeda M., Young N.S., and Kajigaya S. Modest truncation of the major capsid protein abrogates B19 parvovirus capsid formation. J Virol 69 10 (1995) 6567-6571
26. Zorman-Rojs O., Barlic-Maganja D., Mitevski D., Lubke W., and Mundt E. Very virulent infectious bursal disease virus in southeastern Europe. Avian Dis 47 1 (2003) 186-192
27. O'Reilly D.R., Miller L.K., and Luckow V.A. Baculovirus expression vectors: a laboratory manual (1992), Freeman, New York
28. Wang M.Y., and Doong S.R. A pH-based fed-batch process for the production of a chimeric recombinant infectious bursal disease virus (IBDV) structural protein (rVP2H) in insect cells. Proc Biochem 35 (2000) 877-884
29. Chung Y.T., Yu S.L., and Shieh H.K.H.L.L. Characterization of the nucleotide sequences of the VP2 and a Part of VP4 gene of infectious bursal disease virus strain P3009 isolated in Taiwan. Taiwan J Vet Med Anim Husb 65 (1995) 205-213
30. Lai S.Y., Ho J.Y., and Wang M.Y. PCR method for detecting recombinant baculoviruses with the insertion of a large gene. Biotechnol Tech 12 (1998) 733-736
31. Lee L.H., and Lukert P.D. Isolation and structure of infectious bursal disease virus. J Chin Soc Vet Sci 12 (1986) 171-182
32. Lee L.H., and Lukert P.D. Adaptation and antigenic variation of infectious bursal disease virus. J Chin Soc Vet Sc 12 (1986) 297-304
33. Pereira S.R.F.G., Travassos C.E.P.F., Huguenim A., Silva A.C.C.G.G.A., and Guimarães M.A.A.M. Western blot detection of infectious bursal disease virus infection. Braz J Med Biol Res 31 (1998) 671-674
34. Muskett J.C., Hopkins I.G., Edwards K.R., and Thornton D.H. Comparison of two infectious bursal disease vaccine strains: efficacy and potential hazards in susceptible and maternally immune birds. Vet Rec 104 15 (1979) 332-334
35. Cheng Y.S., Lee M.S., Lai S.Y., Doong S.R., and Wang M.Y. Separation of pure and immunoreactive virus-like particles using gel filtration chromatography following immobilized metal ion affinity chromatography. Biotechnol Prog 17 2 (2001) 318-325
36. Ho J.Y., Lai S.Y., and Lee LHYW.M. Expression, purification, and characterization of the infectious bursal disease virus-like particles produced by insect cells. J Chin Chem Soc 46 (1999) 743-750
37. Schnitzler D., Bernstein F., Muller H., and Becht H. The genetic basis for the antigenicity of the VP2 protein of the infectious bursal disease virus. J Gen Virol 74 (1993) 1563-1571
38. Vakharia V.N., Snyder D.B., Lutticken D., Mengel-Whereat S.A., Savage P.K., Edwards G.H., et al. Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins. Vaccine 12 5 (1994) 452-456
39. Lee M.S., Wang M.Y., Tai Y.J., and Lai S.Y. Characterization of particles formed by the precursor protein VPX of infectious bursal disease virus in insect Hi-5 cells: implication on its proteolytic processing. J Virol Methods 121 2 (2004) 191-199
40. Luque D., Saugar I., Rodriguez J.F., Verdaguer N., Garriga D., Martin C.S., et al. Infectious bursal disease virus capsid assembly and maturation by structural rearrangements of a transient molecular switch. J Virol 81 13 (2007) 6869-6878
41. Garriga D., Querol-Audi J., Abaitua F., Saugar I., Pous J., Verdaguer N., et al. The 2.6-Angstrom structure of infectious bursal disease virus-derived T = 1 particles reveals new stabilizing elements of the virus capsid. J Virol 80 14 (2006) 6895-6905
42. Hulse D.J., and Romero C.H. Partial protection against infectious bursal disease virus through DNA-mediated vaccination with the VP2 capsid protein and chicken IL-2 genes. Vaccine 22 9-10 (2004) 1249-1259
43. Kumar S., Ahi Y.S., Salunkhe S.S., Koul M., Tiwari A.K., Gupta P.K., et al. Effective protection by high efficiency bicistronic DNA vaccine against infectious bursal disease virus expressing VP2 protein and chicken IL-2. Vaccine 27 6 (2009) 864-869